Vaccine Market Size Worth USD 77.90 Billion in 2028 - PowerPoint PPT Presentation

About This Presentation
Title:

Vaccine Market Size Worth USD 77.90 Billion in 2028

Description:

Rise in prevalence of infectious diseases and increased investment in vaccine development activities are some key factors driving market revenue growth Market Size – USD 44.82 Billion in 2020, Market Growth – at a CAGR of 7.1%, Market Trends – Advancements in technology – PowerPoint PPT presentation

Number of Views:4
Date added: 24 June 2022
Slides: 14
Provided by: Licasmith

less

Transcript and Presenter's Notes

Title: Vaccine Market Size Worth USD 77.90 Billion in 2028


1
Vaccine Market Report 2018-2028
www.emergenresearch.com
Vaccine Market Size Worth USD 77.90 Billion in
2028
2
Our Model
Market Analysis
Financial Analysis
Distribution Channel Analysis
Brand Analysis
Custom Market Intelligence
Competitor Analysis
Product Analysis
Custom Research
www.emergenresearch.com
Demand Analysis
Risk Analysis
3
Business Plan Parameters
End Use Analysis
Demand Availability Analytics
Market Entry Strategy
Restructuring Revival
New Product Strategy
Product Planning / Strategy
SWOT Analysis
Marketing / Distribution Channel Feasibility
www.emergenresearch.com
Customer Identification Survey
Competitive Landscape / MA Feasibility
www.emergenresearch.com
4
Industries We Cater to
www.emergenresearch.com
5
5
Market Summary
  • The global vaccine market size is expected to
    reach USD 77.90 Billion at a steady revenue CAGR
    of 7.1 in 2028, according to latest analysis by
    Emergen Research. An increase in prevalence of
    infectious diseases is a key factor driving
    global vaccine market revenue growth.
  • Some Key Highlights from the Report
  • In August 2021, Pfizer and BioNTech announced a
    collaboration with Brazils Eurofarma to
    manufacture COVID-19 vaccine doses for Latin
    American countries. COMIRNATY will be
    manufactured by Eurofarma with Pfizers and
    BioNTechs COVID-19 vaccine manufacturing and
    supply chain network. Eurofarma will get raw
    materials for the drug from the U.S. and
    manufacturing will begin in 2022. Vaccine
    production is expected to exceed 100 million
    finished doses yearly which will be exclusively
    distributed within Latin America.
  • Monovalent vaccine segment revenue is expected to
    register a significant growth rate during the
    forecast period. A monovalent vaccine is designed
    to immunize single microorganism and antigen (for
    example, measles vaccine). This type of vaccine
    is preferable for development of a strong immune
    response.

www.emergenresearch.com
6
Market Summary
  • Key Highlights From The Report
  • Toxoid vaccines are administered to adults as
    well as children to protect them against tetanus
    and diphtheria. This vaccine is administered to
    induce an immune response to protect against
    disease caused by toxins secreted by specific
    bacteria. This vaccine is part of a course of
    multiple doses and booster shots are given when
    travelling to high-risk countries.
  • Influenza segment accounted for a significant
    revenue in 2020. Influenza vaccines are seasonal
    flu shot that protects against the 34 types of
    influenza viruses such as viral respiratory
    illness that spreads quite easily. The flu can
    lead to serious health complications and even
    death. CDC recommends a yearly influenza vaccine
    for people six months and older. Pregnant women
    should also get the vaccine during each
    pregnancy.
  • Some major players in the market include Pfizer,
    Inc., CSL Limited, Merck Co., Inc.,
    AstraZeneca, Johnson Johnson, Serum Institute
    of India Pvt., Ltd., GlaxoSmithKline PLC, Sanofi
    Pasteur SA, Emergent Biosolutions, Inc., and
    Biological E.
  • Request Free Sample Copy _at_ https//www.emergenrese
    arch.com/request-sample/290

ww.emergenresearch.com
7
Market Summary
  • Emergen Research has segmented the global Vaccine
    market on the basis of type, patient type,
    technology, disease, route of administration, and
    region
  • Type Outlook (Revenue, USD Billion 2018-2028)
  • Monovalent Vaccines
  • Multivalent Vaccines
  • Patient Type Outlook (Revenue, USD Billion
    2018-2028)
  • Pediatric Patients
  • Adult Patients
  • Read More _at_ https//www.emergenresearch.com/indust
    ry-report/vaccine-market

8
Market Summary
  • Technology Outlook (Revenue, USD Billion
    2018-2028)
  • Inactivated Subunit Vaccines
  • Conjugate Vaccines
  • Recombinant Vaccines
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Route of Administration Outlook (Revenue, USD
    Billion 2018-2028)
  • Oral Administration
  • Intramuscular and Subcutaneous Administration
  • Others
  • Request for Customization _at_ https//www.emergenres
    earch.com/request-for-customization/290

9
Parameter Details
Market Size Estimation Period 2020-2027
Base Year Considered 2019
Historical Data 2016-2018
Forecast Period 2020-2028
Quantitative Units Volume Thousand Tons, Revenue in USD billion CAGR from 2020 to 2027
Segments Covered Type, End user, Materials used, Region
Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Customization Scope 10 hours of free customization expert consultation
Pricing and Purchase Options Explore Different Purchase Options Request for Discount to Avail New Year Discount
MARKET SEGMENTATION
www.emergenresearch.com
10
Regional Share Dynamics
www.emergenresearch.com
11
LATEST PUBLICATIONS
Latest published reports from the ICT by Emergen
Research Soil Testing Equipment
Market Irrigation Automation Market Push to Talk
(PTT) Market Organic Electronics
Market Industrial Sensors Market Power Monitoring
Market Temperature Monitoring Systems
Market Environmental Testing Equipment Market  
www.emergenresearch.com
12
About Us
At Emergen Research, we believe in advancing with
technology. We are a growing market research and
strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially
market-disrupting technologies that are predicted
to become more prevalent in the coming
decade. Our expertise umbrellas the
technological environment of all major
industries, and our services help you map your
actions to ensure optimal yield. Our analysts
utilize their market proficiency to offer
actionable insights that help our clients
implement profitable strategies and optimize
their return on investment. Our services are
wide-ranging, right from technological
environment analysis to technological profiling
that highlights the existing opportunities in the
market you can capitalize on to stay ahead of
your competitors.
www.emergenresearch.com
13
Lets Talk Contact Information
Reach out to us and our Research Executives will
ensure you get the report that meets all your
requirements and address all your concerns.
14671 110 Avenue, Surrey, British Columbia, V3R2A9
www.emergenresearch.com
www.emergenresearch.com
sales_at_emergenresearch.com
1 (604) 757-9756
Write a Comment
User Comments (0)
About PowerShow.com